138 related articles for article (PubMed ID: 2160056)
41. In vivo study of NMDA-sensitive glutamate receptor by fluorothienylcyclohexylpiperidine [correction of fluorothienylcycloexylpiperidine], a possible ligand for positron emission tomography.
Ferrarese C; Guidotti A; Costa E; Miletich RS; Rice KC; de Costa BR; Fulham MJ; Di Chiro G
Neuropharmacology; 1991 Aug; 30(8):899-905. PubMed ID: 1685770
[TBL] [Abstract][Full Text] [Related]
42. Stereoselective antagonism of NMDA-stimulated noradrenaline release from rat hippocampal slices by MK-801.
Lalies M; Middlemiss DN; Ransom R
Neurosci Lett; 1988 Sep; 91(3):339-42. PubMed ID: 2847087
[TBL] [Abstract][Full Text] [Related]
43. 1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex.
Marvizón JC; Lewin AH; Skolnick P
J Neurochem; 1989 Mar; 52(3):992-4. PubMed ID: 2465385
[TBL] [Abstract][Full Text] [Related]
44. Identification and characterization of a high-affinity glutamate-controlled TCP binding site in rat brain postsynaptic densities.
Foucaud B; Gombos G
Eur J Pharmacol; 1990 Dec; 189(6):355-62. PubMed ID: 1981559
[TBL] [Abstract][Full Text] [Related]
45. Characterization of D-3,4-cyclopropylglutamates as N-methyl-D-aspartate receptor agonists.
Monahan JB; Hood WF; Compton RP; Cordi AA; Snyder JP; Pellicciari R; Natalini B
Neurosci Lett; 1990 May; 112(2-3):328-32. PubMed ID: 2163042
[TBL] [Abstract][Full Text] [Related]
46. CGP 31358 binds to a site on the NMDA receptor that is coupled to both the transmitter recognition site and the channel domain.
Baud J; Thedinga K; Portet C; Schmutz M; Bittiger H; Bischoff S; Hauser K; Benedict M; Meier R; Fagg GE
Neurosci Lett; 1989 Dec; 107(1-3):184-8. PubMed ID: 2575726
[TBL] [Abstract][Full Text] [Related]
47. The N-methyl-D-aspartate receptor channel complex and the sigma site have different target sizes.
Wong EH; Nielsen M
Eur J Pharmacol; 1989 Dec; 172(6):493-6. PubMed ID: 2482189
[TBL] [Abstract][Full Text] [Related]
48. [3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients.
Kornhuber J; Mack-Burkhardt F; Riederer P; Hebenstreit GF; Reynolds GP; Andrews HB; Beckmann H
J Neural Transm; 1989; 77(2-3):231-6. PubMed ID: 2547892
[TBL] [Abstract][Full Text] [Related]
49. The competitive NMDA receptor antagonist, CPP, allosterically modulates NMDA receptor associated PCP binding sites in the absence of steric hinderance.
Reid AA; Bowen WD; Setterlund C; Rothman RB
NIDA Res Monogr; 1990; 105():339-40. PubMed ID: 1678869
[No Abstract] [Full Text] [Related]
50. Mg2+ protects against PCP-induced cerebrovasospasms and vascular damage in rat brain.
Huang QF; Gebrewold A; Altura BT; Altura BM
Magnes Trace Elem; 1990; 9(1):44-6. PubMed ID: 2158788
[TBL] [Abstract][Full Text] [Related]
51. An endogenous modulator of N-methyl-D-aspartate receptor-coupled glycine receptors.
Marvizón JC; Skolnick P
Eur J Pharmacol; 1990 Jan; 188(1):23-32. PubMed ID: 2155119
[TBL] [Abstract][Full Text] [Related]
52. Autoradiographic evidence that NMDA receptor-coupled channels are located postsynaptically and not presynaptically in the perforant path-dentate granule cell system of the rat hippocampal formation.
Bekenstein JW; Bennett JP; Wooten GF; Lothman EW
Brain Res; 1990 Apr; 514(2):334-42. PubMed ID: 2162712
[TBL] [Abstract][Full Text] [Related]
53. Modulatory effects of aluminum, calcium, lithium, magnesium, and zinc ions on [3H]MK-801 binding in human cerebral cortex.
Hubbard CM; Redpath GT; Macdonald TL; VandenBerg SR
Brain Res; 1989 May; 486(1):170-4. PubMed ID: 2541870
[TBL] [Abstract][Full Text] [Related]
54. Solubilization of the N-methyl-D-aspartate receptor channel complex from rat and porcine brain.
McKernan RM; Castro S; Poat JA; Wong EH
J Neurochem; 1989 Mar; 52(3):777-85. PubMed ID: 2465380
[TBL] [Abstract][Full Text] [Related]
55. Metaphit fails to antagonize PCP-induced passive avoidance deficit.
Danysz W
Pharmacol Biochem Behav; 1991 Jan; 38(1):231-3. PubMed ID: 1826788
[TBL] [Abstract][Full Text] [Related]
56. NMDA receptor channels: labeling of MK-801 with iodine-125 and fluorine-18.
Wieland DM; Kilbourn MR; Yang DJ; Laborde E; Gildersleeve DL; Van Dort ME; Pirat JL; Ciliax BJ; Young AB
Int J Rad Appl Instrum A; 1988; 39(12):1219-25. PubMed ID: 2851002
[TBL] [Abstract][Full Text] [Related]
57. Characterization of polyamines having agonist, antagonist, and inverse agonist effects at the polyamine recognition site of the NMDA receptor.
Williams K; Dawson VL; Romano C; Dichter MA; Molinoff PB
Neuron; 1990 Aug; 5(2):199-208. PubMed ID: 2166545
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and structure-activity relationship of C5-substituted analogues of (+-)-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine [(+-)-desmethyl-MK801]: ligands for the NMDA receptor-coupled phencyclidine binding site.
Monn JA; Thurkauf A; Mattson MV; Jacobson AE; Rice KC
J Med Chem; 1990 Mar; 33(3):1069-76. PubMed ID: 2155320
[TBL] [Abstract][Full Text] [Related]
59. The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences.
Woodruff GN; Foster AC; Gill R; Kemp JA; Wong EH; Iversen LL
Neuropharmacology; 1987 Jul; 26(7B):903-9. PubMed ID: 2821432
[TBL] [Abstract][Full Text] [Related]
60. Nicotine reduces the binding of [3H]MK-801 to brain membranes, but not via the stimulation of high-affinity nicotinic receptors.
Court JA; Piggott MA; Perry EK
Brain Res; 1990 Aug; 524(2):319-21. PubMed ID: 2292014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
